Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.12 USD | +8.33% | +6.85% | +149.60% |
05-21 | Lexaria Bioscience Secures New Hypertension, Epilepsy Patents in US; Shares Rise | MT |
05-17 | Lexaria Bioscience Corp. Announces Dosing Begins in Comprehensive GLP-1 Animal Study | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+149.60% | 40.2M | |
+38.51% | 727B | |
+31.74% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.44% | 205B | |
-5.97% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- LEXX Stock
- News Lexaria Bioscience Corp.
- Transcript : Lexaria Bioscience Corp. Presents at Benzinga Virtual Global Small Cap Conference, May-13-2021 03